rdf:type |
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0005684,
umls-concept:C0022341,
umls-concept:C0027651,
umls-concept:C0034897,
umls-concept:C0205210,
umls-concept:C0205281,
umls-concept:C0684224,
umls-concept:C1274040,
umls-concept:C1511726,
umls-concept:C1516213,
umls-concept:C1556094,
umls-concept:C1578536
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-3-20
|
pubmed:abstractText |
To characterize the clinical outcome in a large contemporary series of Japanese patients with newly diagnosed Ta, T1 non-muscle invasive bladder cancer who underwent transurethral bladder tumor resection with or without intravesical chemotherapy or Bacillus Calmette-Guérin (BCG) therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1442-2042
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
279-86
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19207609-Administration, Intravesical,
pubmed-meshheading:19207609-Adult,
pubmed-meshheading:19207609-Aged,
pubmed-meshheading:19207609-Aged, 80 and over,
pubmed-meshheading:19207609-BCG Vaccine,
pubmed-meshheading:19207609-Carcinoma, Transitional Cell,
pubmed-meshheading:19207609-Cause of Death,
pubmed-meshheading:19207609-Chemotherapy, Adjuvant,
pubmed-meshheading:19207609-Combined Modality Therapy,
pubmed-meshheading:19207609-Cystectomy,
pubmed-meshheading:19207609-Databases, Factual,
pubmed-meshheading:19207609-Female,
pubmed-meshheading:19207609-Humans,
pubmed-meshheading:19207609-Japan,
pubmed-meshheading:19207609-Kaplan-Meier Estimate,
pubmed-meshheading:19207609-Logistic Models,
pubmed-meshheading:19207609-Male,
pubmed-meshheading:19207609-Middle Aged,
pubmed-meshheading:19207609-Muscle, Smooth,
pubmed-meshheading:19207609-Neoplasm Invasiveness,
pubmed-meshheading:19207609-Neoplasm Recurrence, Local,
pubmed-meshheading:19207609-Neoplasm Staging,
pubmed-meshheading:19207609-Probability,
pubmed-meshheading:19207609-Prognosis,
pubmed-meshheading:19207609-Proportional Hazards Models,
pubmed-meshheading:19207609-Registries,
pubmed-meshheading:19207609-Risk Assessment,
pubmed-meshheading:19207609-Societies, Medical,
pubmed-meshheading:19207609-Statistics, Nonparametric,
pubmed-meshheading:19207609-Survival Analysis,
pubmed-meshheading:19207609-Treatment Outcome,
pubmed-meshheading:19207609-Urinary Bladder Neoplasms,
pubmed-meshheading:19207609-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
|
pubmed:affiliation |
Working Group of the Bladder Cancer Registration Committee of the Japanese Urological Association, Department of Urology, Keio University School of Medicine, Tokyo, Japan. eiji-k@kb3.so-net.ne.jp
|
pubmed:publicationType |
Journal Article
|